News CareDx, Inc

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-13 pm EDT			5-day change	1st Jan Change
14.98 ^USD	+1.01%		+47.15%	+24.83%

May. 13	Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating	MT
May. 10	Sector Update: Health Care Stocks Higher Late Afternoon	MT

CareDx : 2024 Proxy Statement	May. 13	PU
Stephens Adjusts Price Target on CareDx to $18 From $15, Maintains Overweight Rating	May. 13	MT
Sector Update: Health Care Stocks Higher Late Afternoon	May. 10	MT
CareDx Shares Rise After Q1 Results Beat Estimates	May. 10	MT
CareDx: Q1 Earnings Snapshot	May. 09	AQ
Earnings Flash (CDNA) CAREDX Reports Q1 Revenue $72M, vs. Street Est of $63.1M	May. 09	MT
Transcript : CareDx, Inc, Q1 2024 Earnings Call, May 09, 2024	May. 09
CareDx Reports First Quarter 2024 Results	May. 09	BU
CareDx, Inc Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 09	CI
CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)	May. 03	BU
North American Morning Briefing : Stock Futures -3-	May. 02	DJ
CareDx to Report First Quarter 2024 Financial Results	Apr. 29	BU
CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)	Apr. 19	BU
CareDx Appoints John Hanna as CEO, President	Apr. 16	MT
CareDx Appoints John W. Hanna as its New President and Chief Executive Officer	Apr. 16	BU
CareDx, Inc Appoints John W. Hanna as Chief Executive Officer	Apr. 16	CI
CareDx, Inc Appoints John W. Hanna as President and Member of the Board of Directors	Apr. 16	CI
Illumina CFO Goswami to depart, former Summit Therapeutics exec Dhingra to succeed	Apr. 09	RE
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting	Apr. 09	BU
CareDx Appoints Bryan Riggsbee to Its Board of Directors	Mar. 11	BU

No results for this search